Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127448981 | 12744898 | 1 | I | 20160831 | 20160915 | 20160915 | EXP | KE-CIPLA LTD.-2016US18240 | CIPLA | 0.00 | Y | 0.00000 | 20160915 | OT | US | KE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127448981 | 12744898 | 1 | PS | Tenofovir/Emtricitabine | EMTRICITABINETENOFOVIR | 1 | Unknown | 200MG/ 300MG, UNK | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127448981 | 12744898 | 1 | Prophylaxis against HIV infection |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127448981 | 12744898 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127448981 | 12744898 | Exposure during pregnancy | |
127448981 | 12744898 | Foetal death |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |